Purpose:
To collect information to observe the safety and effectiveness of transcatheter aortic valve replacement (TAVR) in moderate, symptomatic aortic stenosis and before aortic stenosis becomes severe.
The TAVR valve that will be studied in this trial has been approved as a safe and effective treatment for use in severe, symptomatic aortic stenosis condition only.
Description:
TAVR is a treatment to replace your natural valve with an artificial valve that is made from pig tissue supported by a metal frame. The artificial valve is designed to work just like a healthy natural valve, opening and closing with each heartbeat. To place TAVR in your heart requires a minimally invasive medical procedure.
Inclusion Criteria-including but may not be limited to:
Age 65 and over with moderate, symptomatic aortic stenosis condition. Symptoms including but not limited to:
To Participate: Please contact the Network Office of Research and Innovation at 610-402-9543.
For additional information:
ClinicalTrials.gov Identifier: NCT05149755
1250 S Cedar Crest Blvd
Suite 300
Allentown, PA 18103-6381
United States
1250 S Cedar Crest Blvd
Suite 300
Allentown, PA 18103-6381
United States
3371 Route 100
Suite 305
Macungie, PA 18062-9613
United States